Condition

Advanced and Metastatic Urothelial Cancer (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Taiho Oncology, Inc. (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

futibatinib and pembrolizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

advanced and metastatic urothelial cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced and Metastatic Urothelial Cancer Trial in France, Spain, United States (futibatinib and pembrolizumab)

Recruiting

Advanced and Metastatic Urothelial Cancer

futibatinib and pembrolizumab

San Francisco, California
+17 more

Oct 25, 2022